Posenacaftor
Posenacaftor (PTI-801) is an investigational drug developed by Proteostasis Therapeutics for the treatment of cystic fibrosis (CF), a genetic disorder that affects the lungs and other organs. Reference standards of Posenacaftor API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Posenacaftor
[catalogue_number] => PA 16 4250000
[category_ids] => ,79,80,78,70,82,
[chemical_name] =>
[weight] => 445.52
[form] => C27H27NO5
[cas] => 2095064-05-2
[pslug] => 2095064-05-2-posenacaftor-pa164250000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 16 4250000
Molecular Formula : C27H27NO5
Molecular Weight : 445.52